Blog Posts

Why Let Ready? | Office Rental Space & Leases Near Me

Posted by Liz Seyi on September 20, 2024 at 1:21am 0 Comments

We make finding a home for your business easy.

Using the best property brains in Britain, we’ve made sure that our buildings are fit for a changing future. Our national reach and truly flexible approach to leasing allows us to put the needs of our tenants first.

Introducing Let Ready

Our simple all inclusive packages make moving office easy. Jargon free flexible leases, manageable monthly payments and a dedicated site team to… Continue

Discover the Perfect Nude Lipstick Shade for Every Skin Tone

Posted by Pranali Ahuja on September 20, 2024 at 1:12am 0 Comments

Achieve an effortless, natural look with the perfect nude lipstick. Whether you prefer a soft, barely-there shade or a bold nude statement, finding the right hue can enhance your complexion and complete any makeup look. Explore a variety of nude lipstick tones that flatter every skin type, from fair to deep, and tips for choosing the best finish—matte, satin, or gloss. Let your lips shine naturally!

Careers as Psychologist

Posted by Poddar College on September 20, 2024 at 1:01am 0 Comments

Psychologists typically work with patients that have been diagnosed with more severe mental disorders, such as borderline personality disorder, clinical depression, schizophrenia, and more. Psychologists can also transition into academia or research, rather than clinical or counseling practice. Poddar International College, the best College in Jaipur offers UG course in Psychology.

The various Psychology professions other than Counseling and Therapist include:

Clinical…

Continue

Best Careers after B. Sc. in Biology

Posted by Poddar College on September 20, 2024 at 12:53am 0 Comments

Biology is a fast-growing field with a wide range of high-paying positions. While the highest-paid positions require an extensive amount of training and education, they are considered highly rewarding jobs both emotionally and financially.

As a general perception, Biology students get disappointed if they are not able to become a doctor. Here we would like to throw light on some other good career options in Biology after completing their graduation. Poddar International College, one of…

Continue

Samsung BioLogics Rubbishes Report That It Is In Talks To Acquire Biogen


Samsung BioLogics, on Thursday, denied the media report that claimed the South Korean firm is in talks to buy U.S. drugmaker Biogen Inc

Biogen Inc. $BIIB: $240.00(-7.09%) for more than $40 billion.
“Samsung is at the negotiating table with the sell-side to acquire Biogen,” a senior official at a global investment bank told The Korea Economic Daily on Dec. 29.

U.S. biotech already has an established business relationship with South Korean chaebol. It is a partner in their joint venture called Samsung Bioepis that focuses on making low-cost biosimilars.

Samsung BioLogics, the biotech division of Samsung Group, said in a regulatory filing that the report was “not true,” not saying much on it.

Soon after the availability of the Samsung-Biogen deal report in the public domain on Wednesday, Biogen stock jumped as much as 13% and closed the day with an almost $38 billion market cap.

On the dashboard of Quantale, the social engagement for the Biogen stock amongst the users of Twitter and Reddit fell more than 40%, but the price of each share gained nearly 10% from the previous day close.

A total of 6.81 million shares of the stock exchanged hands, 5.53 million above the average of 1.28 million.

However, in the pre-trading session today, the Biogen stock slipped 6.5%, wiping off the earlier gains that an article from the South Korean business daily catapulted.

The stock opened the market at $245.19 apiece and was trading at a drop of about 8%, at $237.93 12:30 p.m eastern.

Biogen was founded in 1978 by two Nobel Prize laureates– Walter Gilbert and Phillip Sharp. Gilbert was honoured with the Nobel Prize in chemistry for his work in DNA sequencing in 1980, and co-founder Sharp received the prize for his contribution to his discovery of split genes in 1993.

The company is known to discover treatments for nervous system diseases such as multiple sclerosis and Parkinson’s disease. Earlier this year, Biogen had to struggle to get its controversial Alzheimer’s medication approved. Despite the concerns raised by the doctors and researchers, the U.S. Food and Drug Administration okayed the company’s Aduhelm drug for Alzheimer’s disease treatment. The drug’s sales in the third quarter were hardly $300,000, far below the expectations of $12.1 million sales.

In the previous week, the company announced that the cost of the therapy will be halved to $27,200 per year for a patient of average weight.

The stock skyrocketed to $468.55 apiece on June 7, taking Biogen’s market capitalization to about $69 billion following the approval of its Alzheimer’s drug by the U.S. Food and Drug Administration.

Notably, after getting the nod from the U.S. Food and Drug Administration for its Alzheimer’s drug, the stock has fallen nearly 50% but remained in the positive territory overall in the year.

The Cambridge, Massachusetts based company generated $13.4 billion in revenues last year and finished 2020 with an employee headcount of 9,100.

Views: 2

Comment

You need to be a member of On Feet Nation to add comments!

Join On Feet Nation

© 2024   Created by PH the vintage.   Powered by

Badges  |  Report an Issue  |  Terms of Service